APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pipeline Inspection and Diagnostic

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pipeline Inspection and Diagnostic Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchPipeline Inspection and Diagnostic Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Pipeline Inspection and Diagnostic Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Pipeline Inspection and Diagnostic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pipeline Inspection and Diagnostic Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Pipeline Inspection and Diagnostic Market Analysis and Forecast 2026-2032239 pages · $4,950 USD

Market perspective

The global Pipeline Inspection and Diagnostic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pipeline Inspection and Diagnostic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pipeline Inspection and Diagnostic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pipeline Inspection and Diagnostic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pipeline Inspection and Diagnostic market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pipeline Inspection and Diagnostic market include 3B Inspection, 3P Services, ABS Group, Applied Consultants, Inc, Baker Hughes, CJB Ventures, Dekra, ENTEGRA and Intertek, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pipeline Inspection and Diagnostic market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pipeline Inspection and Diagnostic and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pipeline Inspection and Diagnostic revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pipeline Inspection and Diagnostic market.

Pipeline Inspection and Diagnostic Segment by Company

3B Inspection

3P Services

ABS Group

Applied Consultants, Inc

Baker Hughes

CJB Ventures

Dekra

ENTEGRA

Intertek

Liberty Energy Services

MISTRAS Group

NDT Global (Previan)

Omani Company

Onstream Pipeline Inspection Services

PIPECARE

QIS

ROSEN Group

SGS

Sonomatic

TJ Inspection

TUBOSER

WEGAUGE

Pipeline Inspection and Diagnostic Segment by Type

Pipeline Inspection

Pipeline Diagnostic

Pipeline Inspection and Diagnostic Segment by Application

Oil & Gas Industry

Chemical Industry

Water Treatment Industry

Power Generation Industry

Others

Pipeline Inspection and Diagnostic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pipeline Inspection and Diagnostic status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pipeline Inspection and Diagnostic key companies, revenue, market share, and recent developments.

3. To split the Pipeline Inspection and Diagnostic breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pipeline Inspection and Diagnostic market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pipeline Inspection and Diagnostic significant trends, drivers, influence factors in global and regions.

6. To analyze Pipeline Inspection and Diagnostic competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pipeline Inspection and Diagnostic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pipeline Inspection and Diagnostic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pipeline Inspection and Diagnostic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pipeline Inspection and Diagnostic industry.

Chapter 3: Detailed analysis of Pipeline Inspection and Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pipeline Inspection and Diagnostic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pipeline Inspection and Diagnostic in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pipeline Inspection and Diagnostic Industry Trends Table 2. Pipeline Inspection and Diagnostic Industry Drivers Table 3. Pipeline Inspection and Diagnostic Industry Opportunities and Challenges Table 4. Pipeline Inspection and Diagnostic Industry Restraints Table 5. Global Pipeline Inspection and Diagnostic Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pipeline Inspection and Diagnostic Revenue Share by Company (2021-2026) Table 7. Global Pipeline Inspection and Diagnostic Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pipeline Inspection and Diagnostic Key Company Manufacturing Base & Headquarters Table 9. Global Pipeline Inspection and Diagnostic Company, Product Type & Application Table 10. Global Pipeline Inspection and Diagnostic Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pipeline Inspection and Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Pipeline Inspection Table 15. Significant Companies of Pipeline Diagnostic Table 16. Global Pipeline Inspection and Diagnostic Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pipeline Inspection and Diagnostic Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pipeline Inspection and Diagnostic Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pipeline Inspection and Diagnostic Sales Value Share by Type (2021-2026) Table 20. Global Pipeline Inspection and Diagnostic Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Oil & Gas Industry Table 22. Significant Companies of Chemical Industry Table 23. Significant Companies of Water Treatment Industry Table 24. Significant Companies of Power Generation Industry Table 25. Significant Companies of Others Table 26. Global Pipeline Inspection and Diagnostic Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pipeline Inspection and Diagnostic Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Pipeline Inspection and Diagnostic Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Pipeline Inspection and Diagnostic Sales Value Share by Application (2021-2026) Table 30. Global Pipeline Inspection and Diagnostic Sales Value Share by Application (2027-2032) Table 31. Global Pipeline Inspection and Diagnostic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pipeline Inspection and Diagnostic Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Pipeline Inspection and Diagnostic Sales Value Share by Region (2021-2026) Table 34. Global Pipeline Inspection and Diagnostic Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Pipeline Inspection and Diagnostic Sales Value Share by Region (2027-2032) Table 36. Global Pipeline Inspection and Diagnostic Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pipeline Inspection and Diagnostic Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Pipeline Inspection and Diagnostic Sales Value Market Share by Country (2021-2026) Table 39. Global Pipeline Inspection and Diagnostic Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Pipeline Inspection and Diagnostic Sales Value Market Share by Country (2027-2032) Table 41. 3B Inspection Company Information Table 42. 3B Inspection Business Overview Table 43. 3B Inspection Pipeline Inspection and Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. 3B Inspection Pipeline Inspection and Diagnostic Product Portfolio Table 45. 3B Inspection Recent Development Table 46. 3P Services Company Information Table 47. 3P Services Business Overview Table 48. 3P Services Pipeline Inspection and Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. 3P Services Pipeline Inspection and Diagnostic Product Portfolio Table 50. 3P Services Recent Development Table 51. ABS Group Company Information Table 52. ABS Group Business Overview Table 53. ABS Group Pipeline Inspection and Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. ABS Group Pipeline Inspection and Diagnostic Product Portfolio Table 55. ABS Group Recent Development Table 56. Applied Consultants, Inc Company Information Table 57. Applied Consultants, Inc Business Overview Table 58. Applied Consultants, Inc Pipeline Inspection and Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Applied Consultants, Inc Pipeline Inspection and Diagnostic Product Portfolio Table 60. Applied Consultants, Inc Recent Development Table 61. Baker Hughes Company Information Table 62. Baker Hughes Business Overview Table 63. Baker Hughes Pipeline Inspection and Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Baker Hughes Pipeline Inspection and Diagnostic Product Portfolio Table 65. Baker Hughes Recent Development Table 66. CJB Ventures Company Information Table 67. CJB Ventures Business Overview Table 68. CJB Ventures Pipeline Inspection and Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. CJB Ventures Pipeline Inspection and Diagnostic Product Portfolio Table 70. CJB Ventures Recent Development Table 71. Dekra Company Information Table 72. Dekra Business Overview Table 73. Dekra Pipeline Inspection and Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Dekra Pipeline Inspection and Diagnostic Product Portfolio Table 75. Dekra Recent Development Table 76. ENTEGRA Company Information Table 77. ENTEGRA Business Overview Table 78. ENTEGRA Pipeline Inspection and Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. ENTEGRA Pipeline Inspection and Diagnostic Product Portfolio Table 80. ENTEGRA Recent Development Table 81. Intertek Company Information Table 82. Intertek Business Overview Table 83. Intertek Pipeline Inspection and Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Intertek Pipeline Inspection and Diagnostic Product Portfolio Table 85. Intertek Recent Development Table 86. Liberty Energy Services Company Information Table 87. Liberty Energy Services Business Overview Table 88. Liberty Energy Services Pipeline Inspection and Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Liberty Energy Services Pipeline Inspection and Diagnostic Product Portfolio Table 90. Liberty Energy Services Recent Development Table 91. MISTRAS Group Company Information Table 92. MISTRAS Group Business Overview Table 93. MISTRAS Group Pipeline Inspection and Diagnostic Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. MISTRAS Group Pipeline Inspection and Diagnostic Product Portfolio Table 95. MISTRAS Group Recent Development Table 96. NDT Global (Previan) Company Information Table 97. NDT Global (Previan) Business Overview Table 98. NDT Global (Previan) Pipeline Inspection and Diagnostic Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. NDT Global (Previan) Pipeline Inspection and Diagnostic Product Portfolio Table 100. NDT Global (Previan) Recent Development Table 101. Omani Company Company Information Table 102. Omani Company Business Overview Table 103. Omani Company Pipeline Inspection and Diagnostic Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Omani Company Pipeline Inspection and Diagnostic Product Portfolio Table 105. Omani Company Recent Development Table 106. Onstream Pipeline Inspection Services Company Information Table 107. Onstream Pipeline Inspection Services Business Overview Table 108. Onstream Pipeline Inspection Services Pipeline Inspection and Diagnostic Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Onstream Pipeline Inspection Services Pipeline Inspection and Diagnostic Product Portfolio Table 110. Onstream Pipeline Inspection Services Recent Development Table 111. PIPECARE Company Information Table 112. PIPECARE Business Overview Table 113. PIPECARE Pipeline Inspection and Diagnostic Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. PIPECARE Pipeline Inspection and Diagnostic Product Portfolio Table 115. PIPECARE Recent Development Table 116. QIS Company Information Table 117. QIS Business Overview Table 118. QIS Pipeline Inspection and Diagnostic Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. QIS Pipeline Inspection and Diagnostic Product Portfolio Table 120. QIS Recent Development Table 121. ROSEN Group Company Information Table 122. ROSEN Group Business Overview Table 123. ROSEN Group Pipeline Inspection and Diagnostic Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. ROSEN Group Pipeline Inspection and Diagnostic Product Portfolio Table 125. ROSEN Group Recent Development Table 126. SGS Company Information Table 127. SGS Business Overview Table 128. SGS Pipeline Inspection and Diagnostic Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. SGS Pipeline Inspection and Diagnostic Product Portfolio Table 130. SGS Recent Development Table 131. Sonomatic Company Information Table 132. Sonomatic Business Overview Table 133. Sonomatic Pipeline Inspection and Diagnostic Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Sonomatic Pipeline Inspection and Diagnostic Product Portfolio Table 135. Sonomatic Recent Development Table 136. TJ Inspection Company Information Table 137. TJ Inspection Business Overview Table 138. TJ Inspection Pipeline Inspection and Diagnostic Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. TJ Inspection Pipeline Inspection and Diagnostic Product Portfolio Table 140. TJ Inspection Recent Development Table 141. TUBOSER Company Information Table 142. TUBOSER Business Overview Table 143. TUBOSER Pipeline Inspection and Diagnostic Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. TUBOSER Pipeline Inspection and Diagnostic Product Portfolio Table 145. TUBOSER Recent Development Table 146. WEGAUGE Company Information Table 147. WEGAUGE Business Overview Table 148. WEGAUGE Pipeline Inspection and Diagnostic Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. WEGAUGE Pipeline Inspection and Diagnostic Product Portfolio Table 150. WEGAUGE Recent Development Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Pipeline Inspection and Diagnostic Product Image Figure 2. Global Pipeline Inspection and Diagnostic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pipeline Inspection and Diagnostic Market Size (2021-2032) & (US$ Million) Figure 4. Global Pipeline Inspection and Diagnostic Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Pipeline Inspection Image Figure 8. Pipeline Diagnostic Image Figure 9. Global Pipeline Inspection and Diagnostic Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pipeline Inspection and Diagnostic Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pipeline Inspection and Diagnostic Sales Value Share by Type (2021-2032) Figure 12. Oil & Gas Industry Image Figure 13. Chemical Industry Image Figure 14. Water Treatment Industry Image Figure 15. Power Generation Industry Image Figure 16. Others Image Figure 17. Global Pipeline Inspection and Diagnostic Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pipeline Inspection and Diagnostic Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pipeline Inspection and Diagnostic Sales Value Share by Application (2021-2032) Figure 20. Global Pipeline Inspection and Diagnostic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Pipeline Inspection and Diagnostic Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Pipeline Inspection and Diagnostic Sales Value (2021-2032) & (US$ Million) Figure 23. North America Pipeline Inspection and Diagnostic Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Pipeline Inspection and Diagnostic Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Pipeline Inspection and Diagnostic Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Pipeline Inspection and Diagnostic Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Pipeline Inspection and Diagnostic Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Pipeline Inspection and Diagnostic Sales Value (2021-2032) & (US$ Million) Figure 29. South America Pipeline Inspection and Diagnostic Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Pipeline Inspection and Diagnostic Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Pipeline Inspection and Diagnostic Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Pipeline Inspection
  • Pipeline Diagnostic
Applications
  • Oil & Gas Industry
  • Chemical Industry
  • Water Treatment Industry
  • Power Generation Industry
  • Others
Companies covered
  • 3B Inspection
  • 3P Services
  • ABS Group
  • Applied Consultants, Inc
  • Baker Hughes
  • CJB Ventures
  • Dekra
  • ENTEGRA
  • Intertek
  • Liberty Energy Services
  • MISTRAS Group
  • NDT Global (Previan)
  • Omani Company
  • Onstream Pipeline Inspection Services
  • PIPECARE
  • QIS
  • ROSEN Group
  • SGS
  • Sonomatic
  • TJ Inspection
  • TUBOSER
  • WEGAUGE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pipeline Inspection and Diagnostic Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pipeline Inspection and Diagnostic Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pipeline Inspection and Diagnostic Market Dynamics
  1. 2.1 Pipeline Inspection and Diagnostic Industry Trends
  2. 2.2 Pipeline Inspection and Diagnostic Industry Drivers
  3. 2.3 Pipeline Inspection and Diagnostic Industry Opportunities and Challenges
  4. 2.4 Pipeline Inspection and Diagnostic Industry Restraints
3 Pipeline Inspection and Diagnostic Market by Company
  1. 3.1 Global Pipeline Inspection and Diagnostic Company Revenue Ranking in 2025
  2. 3.2 Global Pipeline Inspection and Diagnostic Revenue by Company (2021-2026)
  3. 3.3 Global Pipeline Inspection and Diagnostic Company Ranking (2024-2026)
  4. 3.4 Global Pipeline Inspection and Diagnostic Company Manufacturing Base and Headquarters
  5. 3.5 Global Pipeline Inspection and Diagnostic Company Product Type and Application
  6. 3.6 Global Pipeline Inspection and Diagnostic Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pipeline Inspection and Diagnostic Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pipeline Inspection and Diagnostic Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pipeline Inspection and Diagnostic Market by Type
  1. 4.1 Pipeline Inspection and Diagnostic Type Introduction
  2. 4.1.1 Pipeline Inspection
  3. 4.1.2 Pipeline Diagnostic
  4. 4.2 Global Pipeline Inspection and Diagnostic Sales Value by Type
  5. 4.2.1 Global Pipeline Inspection and Diagnostic Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pipeline Inspection and Diagnostic Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pipeline Inspection and Diagnostic Sales Value Share by Type (2021-2032)
5 Pipeline Inspection and Diagnostic Market by Application
  1. 5.1 Pipeline Inspection and Diagnostic Application Introduction
  2. 5.1.1 Oil & Gas Industry
  3. 5.1.2 Chemical Industry
  4. 5.1.3 Water Treatment Industry
  5. 5.1.4 Power Generation Industry
  6. 5.1.5 Others
  7. 5.2 Global Pipeline Inspection and Diagnostic Sales Value by Application
  8. 5.2.1 Global Pipeline Inspection and Diagnostic Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Pipeline Inspection and Diagnostic Sales Value by Application (2021-2032)
  10. 5.2.3 Global Pipeline Inspection and Diagnostic Sales Value Share by Application (2021-2032)
6 Pipeline Inspection and Diagnostic Regional Value Analysis
  1. 6.1 Global Pipeline Inspection and Diagnostic Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pipeline Inspection and Diagnostic Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pipeline Inspection and Diagnostic Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pipeline Inspection and Diagnostic Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pipeline Inspection and Diagnostic Sales Value (2021-2032)
  7. 6.3.2 North America Pipeline Inspection and Diagnostic Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pipeline Inspection and Diagnostic Sales Value (2021-2032)
  10. 6.4.2 Europe Pipeline Inspection and Diagnostic Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pipeline Inspection and Diagnostic Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pipeline Inspection and Diagnostic Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pipeline Inspection and Diagnostic Sales Value (2021-2032)
  16. 6.6.2 South America Pipeline Inspection and Diagnostic Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pipeline Inspection and Diagnostic Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pipeline Inspection and Diagnostic Sales Value Share by Country, 2025 VS 2032
7 Pipeline Inspection and Diagnostic Country-level Value Analysis
  1. 7.1 Global Pipeline Inspection and Diagnostic Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pipeline Inspection and Diagnostic Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pipeline Inspection and Diagnostic Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pipeline Inspection and Diagnostic Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pipeline Inspection and Diagnostic Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pipeline Inspection and Diagnostic Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pipeline Inspection and Diagnostic Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 3B Inspection
  2. 8.1.1 3B Inspection Company Information
  3. 8.1.2 3B Inspection Business Overview
  4. 8.1.3 3B Inspection Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  5. 8.1.4 3B Inspection Pipeline Inspection and Diagnostic Product Portfolio
  6. 8.1.5 3B Inspection Recent Developments
  7. 8.2 3P Services
  8. 8.2.1 3P Services Company Information
  9. 8.2.2 3P Services Business Overview
  10. 8.2.3 3P Services Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  11. 8.2.4 3P Services Pipeline Inspection and Diagnostic Product Portfolio
  12. 8.2.5 3P Services Recent Developments
  13. 8.3 ABS Group
  14. 8.3.1 ABS Group Company Information
  15. 8.3.2 ABS Group Business Overview
  16. 8.3.3 ABS Group Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ABS Group Pipeline Inspection and Diagnostic Product Portfolio
  18. 8.3.5 ABS Group Recent Developments
  19. 8.4 Applied Consultants, Inc
  20. 8.4.1 Applied Consultants, Inc Company Information
  21. 8.4.2 Applied Consultants, Inc Business Overview
  22. 8.4.3 Applied Consultants, Inc Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Applied Consultants, Inc Pipeline Inspection and Diagnostic Product Portfolio
  24. 8.4.5 Applied Consultants, Inc Recent Developments
  25. 8.5 Baker Hughes
  26. 8.5.1 Baker Hughes Company Information
  27. 8.5.2 Baker Hughes Business Overview
  28. 8.5.3 Baker Hughes Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Baker Hughes Pipeline Inspection and Diagnostic Product Portfolio
  30. 8.5.5 Baker Hughes Recent Developments
  31. 8.6 CJB Ventures
  32. 8.6.1 CJB Ventures Company Information
  33. 8.6.2 CJB Ventures Business Overview
  34. 8.6.3 CJB Ventures Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CJB Ventures Pipeline Inspection and Diagnostic Product Portfolio
  36. 8.6.5 CJB Ventures Recent Developments
  37. 8.7 Dekra
  38. 8.7.1 Dekra Company Information
  39. 8.7.2 Dekra Business Overview
  40. 8.7.3 Dekra Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Dekra Pipeline Inspection and Diagnostic Product Portfolio
  42. 8.7.5 Dekra Recent Developments
  43. 8.8 ENTEGRA
  44. 8.8.1 ENTEGRA Company Information
  45. 8.8.2 ENTEGRA Business Overview
  46. 8.8.3 ENTEGRA Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ENTEGRA Pipeline Inspection and Diagnostic Product Portfolio
  48. 8.8.5 ENTEGRA Recent Developments
  49. 8.9 Intertek
  50. 8.9.1 Intertek Company Information
  51. 8.9.2 Intertek Business Overview
  52. 8.9.3 Intertek Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Intertek Pipeline Inspection and Diagnostic Product Portfolio
  54. 8.9.5 Intertek Recent Developments
  55. 8.10 Liberty Energy Services
  56. 8.10.1 Liberty Energy Services Company Information
  57. 8.10.2 Liberty Energy Services Business Overview
  58. 8.10.3 Liberty Energy Services Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Liberty Energy Services Pipeline Inspection and Diagnostic Product Portfolio
  60. 8.10.5 Liberty Energy Services Recent Developments
  61. 8.11 MISTRAS Group
  62. 8.11.1 MISTRAS Group Company Information
  63. 8.11.2 MISTRAS Group Business Overview
  64. 8.11.3 MISTRAS Group Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MISTRAS Group Pipeline Inspection and Diagnostic Product Portfolio
  66. 8.11.5 MISTRAS Group Recent Developments
  67. 8.12 NDT Global (Previan)
  68. 8.12.1 NDT Global (Previan) Company Information
  69. 8.12.2 NDT Global (Previan) Business Overview
  70. 8.12.3 NDT Global (Previan) Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  71. 8.12.4 NDT Global (Previan) Pipeline Inspection and Diagnostic Product Portfolio
  72. 8.12.5 NDT Global (Previan) Recent Developments
  73. 8.13 Omani Company
  74. 8.13.1 Omani Company Company Information
  75. 8.13.2 Omani Company Business Overview
  76. 8.13.3 Omani Company Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Omani Company Pipeline Inspection and Diagnostic Product Portfolio
  78. 8.13.5 Omani Company Recent Developments
  79. 8.14 Onstream Pipeline Inspection Services
  80. 8.14.1 Onstream Pipeline Inspection Services Company Information
  81. 8.14.2 Onstream Pipeline Inspection Services Business Overview
  82. 8.14.3 Onstream Pipeline Inspection Services Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Onstream Pipeline Inspection Services Pipeline Inspection and Diagnostic Product Portfolio
  84. 8.14.5 Onstream Pipeline Inspection Services Recent Developments
  85. 8.15 PIPECARE
  86. 8.15.1 PIPECARE Company Information
  87. 8.15.2 PIPECARE Business Overview
  88. 8.15.3 PIPECARE Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  89. 8.15.4 PIPECARE Pipeline Inspection and Diagnostic Product Portfolio
  90. 8.15.5 PIPECARE Recent Developments
  91. 8.16 QIS
  92. 8.16.1 QIS Company Information
  93. 8.16.2 QIS Business Overview
  94. 8.16.3 QIS Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  95. 8.16.4 QIS Pipeline Inspection and Diagnostic Product Portfolio
  96. 8.16.5 QIS Recent Developments
  97. 8.17 ROSEN Group
  98. 8.17.1 ROSEN Group Company Information
  99. 8.17.2 ROSEN Group Business Overview
  100. 8.17.3 ROSEN Group Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  101. 8.17.4 ROSEN Group Pipeline Inspection and Diagnostic Product Portfolio
  102. 8.17.5 ROSEN Group Recent Developments
  103. 8.18 SGS
  104. 8.18.1 SGS Company Information
  105. 8.18.2 SGS Business Overview
  106. 8.18.3 SGS Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  107. 8.18.4 SGS Pipeline Inspection and Diagnostic Product Portfolio
  108. 8.18.5 SGS Recent Developments
  109. 8.19 Sonomatic
  110. 8.19.1 Sonomatic Company Information
  111. 8.19.2 Sonomatic Business Overview
  112. 8.19.3 Sonomatic Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Sonomatic Pipeline Inspection and Diagnostic Product Portfolio
  114. 8.19.5 Sonomatic Recent Developments
  115. 8.20 TJ Inspection
  116. 8.20.1 TJ Inspection Company Information
  117. 8.20.2 TJ Inspection Business Overview
  118. 8.20.3 TJ Inspection Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  119. 8.20.4 TJ Inspection Pipeline Inspection and Diagnostic Product Portfolio
  120. 8.20.5 TJ Inspection Recent Developments
  121. 8.21 TUBOSER
  122. 8.21.1 TUBOSER Company Information
  123. 8.21.2 TUBOSER Business Overview
  124. 8.21.3 TUBOSER Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  125. 8.21.4 TUBOSER Pipeline Inspection and Diagnostic Product Portfolio
  126. 8.21.5 TUBOSER Recent Developments
  127. 8.22 WEGAUGE
  128. 8.22.1 WEGAUGE Company Information
  129. 8.22.2 WEGAUGE Business Overview
  130. 8.22.3 WEGAUGE Pipeline Inspection and Diagnostic Revenue and Gross Margin (2021-2026)
  131. 8.22.4 WEGAUGE Pipeline Inspection and Diagnostic Product Portfolio
  132. 8.22.5 WEGAUGE Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst